EMA may ask manufacturers to increase production capacity in response to medicines shortages

The European Medicines Agency has published a list of new recommendations to be implemented on a case-by-case basis, depending on vulnerabilities in the supply chain.
medicines on pharmacy shelves
Depending on the risk to the supply chain, marketing authorisation holders may be asked to "stockpile medicines" as one of the recommended measures

DR P. MARAZZI/SCIENCE PHOTO LIBRARY

Marketing authorisation holders in Europe may be asked to take on new measures, including to “stockpile medicines” and increase manufacturing capacity, to avoid potential shortages of critical medicines in the supply chain.

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Register for free to keep on reading

Access two premium articles as a registered user.

Register

Already an RPS member or registered? Log in

Last updated